FrancophonIA/ELRC3.0 huggingface dataset:
English: Bortezomib Sun is a cancer medicine used to treat multiple myeloma, a blood cancer, in the following groups of patients:
Estonian: Bortezomib Sun on vähiravim, mida kasutatakse hulgimüeloomi (teatud verevähk) raviks järgmistel patsiendirühmadel:
English: For practical information about using Bortezomib Sun, patients should read the package leaflet or contact their doctor or pharmacist.
Estonian: Kui vajate Bortezomib Suni kasutamise praktilisi nõuandeid, lugege pakendi infolehte või pöörduge oma arsti või apteekri poole.
English: • previously untreated adults who cannot have high-dose chemotherapy with blood stem-cell transplantation.
Estonian: • varem ravimata täiskasvanud, kellel ei saa kasutada suures annuses keemiaravi koos vereloome tüvirakkude siirdamisega.
English: When injected under the skin, it is given in the thigh or abdomen (tummy).
Estonian: Kui ravimit süstitakse naha alla, tehakse süst reide või kõhupiirkonda.
English: • previously untreated adults who are going to receive high-dose chemotherapy followed by blood stem-cell transplantation.
Estonian: • varem ravimata täiskasvanud, kellele hakatakse tegema suure annusega keemiaravi, millele järgneb vereloome tüvirakkude siirdamine.
English: It is not intended to provide practical advice on how to use Bortezomib Sun.
Estonian: Hindamisaruandes ei anta Bortezomib Suni kasutamise praktilisi nõuandeid.
English: Bortezomib Sun is available in vials as a 3.5 mg powder to be made up into a solution for injection into a vein or under the skin.
Estonian: Bortezomib Suni turustatakse 3,5 mg süstelahuse pulbrit sisaldavates viaalides; pulbrist valmistatakse veeni või naha alla süstitav lahus.
English: For more information about treatment with Bortezomib Sun, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Estonian: Kui vajate Bortezomib Suniga toimuva ravi kohta lisateavet, lugege palun pakendi infolehte (mis on samuti Euroopa avaliku hindamisaruande osa) või pöörduge oma arsti või apteekri poole.
English: In these patients, Bortezomib Sun is used in combination with melphalan and prednisone;
Estonian: Bortezomib Suni kasutatakse neil patsientidel koos melfalaani ja prednisooniga;
English: The medicine can only be obtained with a prescription and treatment should only be started and given under the supervision of a doctor who has experience in the use of cancer chemotherapy.
Estonian: Bortezomib Sun on retseptiravim ning ravi peab alustama ja toimuma vähi keemiaravis kogenud arsti järelevalve all.
English: For mantle cell lymphoma, Bortezomib Sun is used in combination with rituximab, cyclophosphamide, doxorubicin and prednisone.
Estonian: Mantelrakulise lümfoomi ravis kasutatakse Bortezomib Suni koos rituksimabi, tsüklofosfamiidi, doksorubitsiini ja prednisooniga.
English: When given into a vein, the solution is injected through a catheter (a thin sterile tube).
Estonian: Veeni süstimisel manustatakse lahus süstina kateetri (steriilse vooliku) kaudu.
English: Bortezomib Sun contains the active substance bortezomib.
Estonian: Bortezomib Sun sisaldab toimeainena bortesomiibi.
English: Why is Bortezomib Sun approved?
Estonian: Miks Bortezomib Sun heaks kiideti?
English: How is Bortezomib Sun used?
Estonian: Kuidas Bortezomib Suni kasutatakse?
English: Therefore, the CHMP's view was that, as for Velcade, the benefit outweighs the identified risk.
Estonian: Seetõttu on inimravimite komitee arvamusel, et nagu ka Velcade korral, ületab ravimi Bortezomib Suni kasulikkus sellega kaasnevad riskid.
English: The active substance in Bortezomib Sun, bortezomib, is a proteasome inhibitor.
Estonian: Bortezomib Suni toimeaine bortesomiib on proteasoomiinhibiitor.
English: How has Bortezomib Sun been studied?
Estonian: Kuidas Bortezomib Suni uuriti?
English: In this group of patients, Bortezomib Sun is used in combination with dexamethasone, or with dexamethasone plus thalidomide.
Estonian: Selles patsiendirühmas kasutatakse Bortezomib Suni koos deksametasooniga või koos deksametasooni ja talidomiidiga.
English: How does Bortezomib Sun work?
Estonian: Kuidas Bortezomib Sun toimib?
English: Bortezomib Sun is either used on its own in these patients or in combination with pegylated liposomal doxorubicin or dexamethasone;
Estonian: Neil patsientidel kasutatakse Bortezomib Suni kas ainuravimina või koos pegüülitud liposomaalse doksorubitsiini või deksametasooniga;
English: For more information on the use of Bortezomib Sun see the summary of product characteristics (also part of the EPAR).
Estonian: Lisateave Bortezomib Suni kohta on ravimi omaduste kokkuvõttes, mis on samuti Euroopa avaliku hindamisaruande osa.
English: This is a summary of the European public assessment report (EPAR) for Bortezomib Sun.
Estonian: See on ravimi Bortezomib Sun Euroopa avaliku hindamisaruande kokkuvõte.
English: What are the benefits and risks of Bortezomib Sun?
Estonian: Milles seisneb Bortezomib Suni kasulikkus ja mis riskid ravimiga kaasnevad?
English: By 25th November 2013 at the latest
Estonian: Kõige hiljem 25. novembriks 2013
English: The products with only obstetric indications and for which revocation is applicable (instead of variation to the terms of the marketing authorisation) should be recalled from the market by the Marketing Authorisation Holders by 25th November 2013 at the latest.
Estonian: Ainult sünnitusabi näidustustel heakskiidetud ravimid, mille müügiload võetakse tagasi (müügilubade tingimuste muutmise asemel), peavad müügiloa hoidjad turult tagasi kutsuma kõige hiljem 25. novembriks 2013.
English: Date
Estonian: Tähtaeg
English: National Competent Authorities (NCAs) of Member States or Reference Member States (RMS) where applicable, shall ensure that the following conditions are fulfilled by the MAH(s):
Estonian: Liikmesriikide või (kui asjakohane) viiteliikmesriigi riiklikud pädevad asutused peavad tagama, et müügiloa hoidjad täidavad järgmisi tingimusi:
English: Within 30 days after CMDh agreement
Estonian: 30 päeva jooksul pärast koordineerimisrühma seisukohta
English: Annex IV Conditions to the marketing authorisation
Estonian: IV lisa Müügilubade tingimused
English: Conditions to the marketing authorisation
Estonian: Müügilubade tingimused
English: DHPC Communication circulation according to the CMDh agreed communication plan and conditions.
Estonian: Inimravimite vastastikuse tunnustamise ja detsentraliseeritud menetluste koordineerimisrühma heakskiidetud teavevahetuskavale ja tingimustele vastav tervishoiutöötajate teatis
English: The detailed grounds for re-examination were submitted on 2 May 2012.
Estonian: Taasläbivaatamise üksikasjalikud põhjendused esitati 2. mail 2012.
English: Whereas:
Estonian: Arvestades, et:
English: This led to the identification of 251 products.
Estonian: Sellisel viisil tuvastati 251 toodet.
English: A number of deficiencies with the study were noted.
Estonian: Uuringus esines mitmeid puudusi.
English: in which D is the number of molecules.
Estonian: kus D on molekulide arv.
English: Not possible to determine
Estonian: Ei saanud määrata
English: Applicant/ Marketing Authorisation Holder
Estonian: Taotleja / müügiloa hoidja
English: The evaluation detailed in this opinion attempts to address the issue raised by the European Commission on the basis of the available data.
Estonian: Käesolevas arvamuses kirjeldatud hindamise eesmärk on lahendada Euroopa Komisjoni tõstatatud probleemi, tuginedes olemasolevatele andmetele.
English: 20093 Cologno Monzese (MI) ITALY
Estonian: 20093 Cologno Monzese (MI) ITAALIA
English: 8501 Novo Mesto SLOVENIA
Estonian: 8501 Novo Mesto SLOVEENIA
English: These are presented in the table below.
Estonian: Tulemused on loetletud alljärgnevas tabelis.
English: Provet Aspropyrgos 19300, Attik GREECE
Estonian: Provet Aspropyrgos 19300, Attik KREEKA
English: While the general nature of the recommendations has its limitations, the approach used aims to provide pragmatic use of limited resources.
Estonian: Kuigi soovitused on üldise laadi tõttu piiratud, oli selle lähenemise eesmärk võimaldada piiratud ressursside pragmaatilist kasutamist.
English: The Committee was also asked to recommend whether the marketing authorisations should be maintained, varied, suspended or withdrawn.
Estonian: Veterinaarravimite komiteel paluti anda ka soovitused, kas müügiload tuleb säilitada, muuta, peatada või tühistada.
English: La Selva 135 17170 Amer (Gerona) SPAIN
Estonian: La Selva 135 17170 Amer (Gerona) HISPAANIA
English: It is noted that, in practice, the dry period is generally considerably shorter than 20 weeks.
Estonian: Praktikas on märgatud, et kinnisperiood on tavaliselt oluliselt lühem kui 20 nädalat.
English: It is assumed that the recommendations are sufficiently conservative to overcome any concerns relating to these issues.
Estonian: Eeldatavasti on soovitused kõnealuste probleemide lahendamiseks piisavalt konservatiivsed.
English: 40064 Ozzano Emilia (BO) ITALY
Estonian: 40064 Ozzano Emilia (BO) ITAALIA
English: Consideration of realistic safe time spans
Estonian: Realistlike ohutusperioodide arvestamine
English: The statement ‘do not use during the last trimester of pregnancy' was considered appropriate to overcome uncertainties resulting from the identified deficiencies.
Estonian: Väljendit „mitte kasutada tiinuse viimasel trimestril” peeti asjakohaseks, et välistada tuvastatud puudustest tulenev määramatus.
English: The longest half-life reported for marker residue was 25 days.
Estonian: Markerjäägi pikim teatatud poolväärtusaeg oli 25 ööpäeva.
English: Pfizer Holding France 23/25 Avenue du Docteur Lannelongue
Estonian: Prantsusmaa Pfizer Holding France 23/25 Avenue du Docteur Lannelongue
English: 5531 AH Bladel THE NETHERLANDS
Estonian: 5531 AH Bladel
English: D-81379 München GERMANY
Estonian: D-81379 München SAKSAMAA
English: Available data Study 1.
Estonian: Olemasolevad andmed 1. uuring.
English: E-08950 Esplugues de Llobregat (Barselona) SPAIN
Estonian: E-08950 Esplugues de Llobregat (Barselona) HISPAANIA
English: D-10785 Berlin GERMANY
Estonian: D-10785 Berlin SAKSAMAA
English: Available data
Estonian: Olemasolevad andmed
English: The CVMP collected information from national competent authorities on veterinary medicinal products containing these substances.
Estonian: Veterinaarravimite komitee kogus neid toimeaineid sisaldavate veterinaarravimite kohta teavet liikmesriikide pädevatelt asutustelt.
English: Use of the same marker residue was considered appropriate for milk.
Estonian: Sama markerjäägi kasutamist peeti sobivaks ka piima korral.
English: 15 Fleming Street Maroussi 15123 GREECE
Estonian: 15 Fleming Street Maroussi 15123 KREEKA
English: 1348 Luvain-la-Neuve BELGIUM
Estonian: 1348 Luvain-la-Neuve BELGIA
English: 2909 LD Capelle a/d Ijssel THE NETHERLANDS
Estonian: 2909 LD Capelle a/d Ijssel MADALMAAD
English: These cases were considered to have resulted from animals grooming each other.
Estonian: Põhjuseks oletati, et loomad võivad olla üksteist lakkunud.
English: However, in study 4 longer pre-calving periods were investigated.
Estonian: 4. uuringus käsitleti siiski pikemaid poegimiseelseid ooteaegu.
English: Bury St Edmunds Suffolk IP30 9UP UNITED KINGDOM
Estonian: Bury St Edmunds Suffolk IP30 9UP ÜHENDKUNINGRIIK
English: The following equation describes the elimination process in the terminal phase:
Estonian: Lõppfaasi eritumisprotsessi kirjeldab järgmine valem:
English: Novartis Santé Animale 14 Boulevard Richelieu 92500 Rueil Malmaison FRANCE
Estonian: Prantsusmaa Novartis Santé Animale 14 Boulevard Richelieu 92500 Rueil Malmaison PRANTSUSMAA
English: Janssen-Cilag GmbH Johnson & Johnson Platz 1 D-41470 Neuss GERMANY
Estonian: Janssen-Cilag GmbH Johnson & Johnson Platz 1 D-41470 Neuss SAKSAMAA
English: This analysis used the ‘SCLR' (Safe concentrations based on linear regression) method.
Estonian: Selle analüüsi tegemisel kasutati SCLR-meetodit (lineaarsel regressioonil põhinev ohutu kontsentratsioon).
English: Pfizer Hellas AE Mesogeion 243 N.Psichiko 15451 GREECE
Estonian: Pfizer Hellas AE Mesogeion 243 N.Psichiko 15451 KREEKA
English: Janssen-Cilag 1 Rue Camille Desmoulins TSA 91003
Estonian: Prantsusmaa Janssen-Cilag 1 Rue Camille Desmoulins TSA 91003
English: List of the names, pharmaceutical forms, strengths of the veterinary medicinal products, animal species, routes of administration, applicants/marketing authorisation holders in the Member States
Estonian: Veterinaarravimi nimetuste, ravimvormide, tugevuste, loomaliikide, manustamisviiside, taotlejate ja müügilubade hoidjate loetelu liikmesriikides
English: This implies that in general, the ratio between the concentration of a drug in plasma and the concentration in milk will remain constant over time.
Estonian: See tähendab, et üldiselt püsib ravimi plasma- ja piimakontsentratsiooni suhe aja jooksul konstantsena.
English: Luxembourg Pfizer Animal Health S.A. rue Laid Burniat 1
Estonian: Luksemburg Pfizer Animal Health S.A. rue Laid Burniat 1
English: The amount and quality of available data are not comparable with that which would normally form the basis for the establishment of MRLs or withdrawal periods and as a result, the recommendations made are general and conservative, and are not product specific - no distinction is made to account for formulation or strength differences, or for dosage differences.
Estonian: Olemasolevate andmete kogus ja kvaliteet ei ole võrreldavad nendega, mida oleks tavaolukorras vaja jääkide piirnormide või keeluaegade kehtestamiseks, mistõttu on soovitused üldised ja konservatiivsed ega ole tootespetsiifilised - ei arvestata ravimvormide, tugevuste ega annuste erinevusi.
English: However, it must be emphasised that these data are limited, with very few studies specifically addressing the depletion of residues of relevant substances in dry cattle/sheep/goats.
Estonian: Samas tuleb rõhutada, et need andmed on piiratud ja mittelakteerivatel veistel/lammastel/kitsedel nende jääkainete vähenemist spetsiifiliselt käsitlenud uuringuid on väga vähe.
English: Merial Italia S.p.A. via Vittorio Pisani, 16 20100 Milano ITALY
Estonian: via Vittorio Pisani, 16 20100 Milano ITAALIA
English: From these 251 veterinary medicinal products, 96 contain one of the substances mentioned above as a single active substance and the remaining 155 are combination products containing a second non-flukicidal active substance.
Estonian: 251 veterinaarravimist sisaldavad 96 üht nimetatud toimeainet ja ülejäänud 155 on kombineeritud ravimid, mille teine toimeaine ei ole flukitsiid.
English: Loughrea, Co. Galway IRELAND
Estonian: Loughrea, Co. Galway IIRIMAA
English: Consequently, it is concluded that residues in milk can only be expected to be below 10 µg/l if animals are prevented from grooming other (treated) animals.
Estonian: Järelikult võib eeldada, et jääkide kontsentratsioon piimas on alla 10 µg/l siis, kui loomadel takistatakse teiste (ravitud) loomade lakkumist.
English: While residues of nitroxinil in milk may be present largely as nitroxinil (as is the case in fat), there have also been reports of nitroxinil conjugates in milk (Whelan et al., 2011).
Estonian: Kuigi piima nitroksiniilijäägid võivad peamiselt esineda nitroksiniilina (nagu ka rasvkoes), on teatatud ka piimas esinevatest nitroksiniili konjugaatidest (Whelan jt 2011).
English: Based on the considerations above the Committee concluded that a conservative recommendation would be appropriate.
Estonian: Nendel põhjustel järeldas veterinaarravimite komitee, et konservatiivne soovitus on endiselt asjakohane.
English: Quinn's Chemist Bridge Street Crossmolina Co. Mayo IRELAND
Estonian: Quinn's Chemist Bridge Street Crossmolina Co. Mayo IIRIMAA
English: The CVMP recommendation does not represent a formal withdrawal period.
Estonian: Veterinaarravimite komitee soovitus ei käsita ametlikku keeluaega.
English: D-48308 Senden-Bösensell GERMANY
Estonian: D-48308 Senden-Bösensell SAKSAMAA
English: For the purposes of this referral the time interval of 119 days can be equated to half of the gestation period.
Estonian: Käesoleva esildise eesmärkide huvides võib 119ööpäevase aja võrdsustada poole tiinusperioodiga.
English: It is noted that, in practice, the dry period is generally considerably shorter than 81 days or 12 weeks.
Estonian: Samas on kinnisperiood tavaliselt oluliselt lühem kui 81 ööpäeva ehk 12 nädalat.
English: The Committee agreed that, in such cases, and where possible, milk concentrations could be estimated by extrapolation from plasma concentrations.
Estonian: Komitee leidis, et sellistel juhtudel ja võimaluse korral tuleb piimakontsentratsioone hinnata plasmakontsentratsiooni andmeid ekstrapoleerides.
English: Laboratorios Cenavisa, s.a. Cami Pedro Estela, S/N 43205 Reus (Tarragona) SPAIN
Estonian: Laboratorios Cenavisa, s.a. Cami Pedro Estela, S/N 43205 Reus (Tarragona) HISPAANIA
English: Both the immature and mature flukes are harmful to the target species, and each flukicide has varying efficacy against different ages of fluke.
Estonian: Sihtliikidele on kahjulikud nii imiusside noorvormid kui ka täiskasvanud isendid, samuti on igal flukitsiidil varieeruv efektiivsus eri vanuses imiusside suhtes.
English: On 14 February 2011, the European Commission initiated a referral under Article 35 of Directive 2001/82/EC, as amended, for all veterinary medicinal products containing active substances belonging to the class of flukicides for which no MRL has been established in milk intended for use in all ruminants producing milk for human consumption.
Estonian: 14. veebruaril 2011 tegi Euroopa Komisjon muudetud direktiivi 2001/82/EÜ artikli 35 kohase esildise kõikide flukitsiidide klassi toimeaineid sisaldavate veterinaarravimite suhtes, millel puuduvad jääkide piirnormid piimas ja mis on näidustatud kasutamiseks kõigil toidupiima tootvatel mäletsejatel.
English: In the majority of cases transfer of substances from blood plasma to milk (and vice versa) is governed by simple diffusion across the mammary gland epithelium (Rasmussen, 1966); active transport has been rarely reported (Ito and Lee, 2003)3.
Estonian: Enamasti määrab ainete liikumise vereplasmast piima (ja vastupidi) lihtne difusioon läbi piimanäärme epiteeli (Rasmussen 1966), aktiivset transporti on täheldatud harva (Ito ja Lee 2003)3.
English: Maagdenburgstraat 38 7421 ZE Deventer THE NETHERLANDS
Estonian: Maagdenburgstraat 38 7421 ZE Deventer MADALMAAD
English: Although the conclusions shown in the above table are applicable to the flukicidal substance in the product they may not be appropriate for the second active substance.
Estonian: Kuigi ülal tabelis loetletud järeldused kehtivad ravimis sisalduva flukitsiidi kohta, ei pruugi need olla asjakohased teise toimeaine suhtes.
English: The marker residue established for tissues is the ‘sum of extractable residues which may be oxidised to ketotriclabendazole'.
Estonian: Kudede jaoks määratud markerjääk on määratletud kui „ketotriklabendasooliks oksüdeeritavate ekstraheeritavate jääkide summa”.
English: Flukicides play a critical role in the prevention and control of trematode infections.
Estonian: Flukitsiididel on äärmiselt oluline roll imiusside põhjustatud infektsioonide ennetamisel ja tõrjes.
English: This can be done by using empirically derived milk to plasma ratios or, in principle, by using appropriate pharmacokinetic data (as described by Rasmussen, 19661).
Estonian: Selleks saab kasutada piima ja plasma väärtuste empiiriliselt tuletatud suhet või põhimõtteliselt ka asjakohaseid farmakokineetika andmeid (kirjeldus: vt Rasmussen 19661).
English: It is also noteworthy that the CVMP recommendation relating to the use of nitroxinil in cattle is meant to be applicable to all nitroxinil containing products including those with different formulations and strengths.
Estonian: Samuti tuleb märkida, et veterinaarravimite komitee soovitus nitroksiniili kasutamise kohta veistel on ette nähtud kõigile nitroksiniili sisaldavatele ravimitele, sealhulgas ka teistsuguste ravimvormide ja tugevuste korral.
English: While no evidence was available to indicate that the pharmacokinetic and residue depletion behaviour following administration of the different nitroxinil containing products would be identical to that seen in the available study, the conservative approach adopted in the interpretation of the available data ensures that the resulting recommendation is valid for all nitroxinil containing products.
Estonian: Kuivõrd puudusid tõendavad andmed, et nitroksiniili sisaldavate teistsuguste ravimite manustamisjärgne farmakokineetika ja jääkide vähenemise profiil on täpselt sama, kui täheldati kättesaadavas uuringus, tagab konservatiivne lähenemine selle, et kättesaadavate andmete tõlgendamisel saadud soovitus kehtib nitroksiniili sisaldavate kõigi ravimite korral.
English: Univet Limited Tullyvin Cootehill Co. Cavan IRELAND
Estonian: Univet Limited Tullyvin Cootehill Co. Cavan IIRIMAA
English: Carl Fr. Mortensen, Copenhagen 1966.
Estonian: Carl Fr. Mortensen,
English: The conclusions of this referral will remain appropriate even if the recommended milk MRLs are established for the above substances, unless product specific data are submitted to the national competent authorities for the establishment of milk withdrawal periods.
Estonian: Käesoleva esildise järeldused jäävad asjakohasteks ka juhul, kui eelmainitud piirnormid kehtestatakse, välja arvatud juhtudel, kui ravimispetsiifilised andmed esitatakse riiklikele reguleerivatele asutustele piima keeluaegade kehtestamise eesmärgil.
English: While this period of one year is markedly longer than the period of 12 days established for subcutaneously administered clorsulon, it is noteworthy that the only identified oral administration pharmaceutical form containing clorsulon as a single active substance is a bolus, for which the conservative default value is considered appropriate.
Estonian: Kuigi selline üheaastane periood on palju pikem kui subkutaanselt manustatud klorsulooni korral saadud 12 ööpäeva, tuleb märkida, et ainus suukaudne ja toimeainetest ainult klorsulooni sisaldav ravimvorm on boolusannus, mille korral on konservatiivse vaikeväärtuse kasutamine asjakohane.
English: in which T = time (days), dose = total dose (g/kg bw/day), duration = treatment duration (days), bw = bodyweight (kg), A = Avogadro's number = 6.0 * 1023, M = Molar mass (g/mol), t1/2 = terminal elimination half-life (h), and in which
Estonian: (2. valem), kus T = aeg (d), annus = koguannus (g/kg/d), kestus = ravi kestus (d), bw = kehamass (kg), A = Avogadro arv (6,0·1023), M = molaarmass (g/mol), t1/2 = lõplik eliminatsiooni poolväärtusaeg (h), ja kus
English: Northern Ireland UNITED KINGDOM
Estonian: Northern Ireland ÜHENDKUNINGRIIK
English: CT13 9NJ UNITED KINGDOM
Estonian: CT13 9NJ
English: Helmizol Plus Clorsulon mg/bolus
Estonian: Helmizol Plus Klorsuloon mg/bolus
English: In view of the limited data available the Committee considered it appropriate to round these minimum time spans upwards in order to arrive at general recommendations.
Estonian: Kättesaadavate andmete piiratust arvestades pidas veterinaarravimite komitee asjakohaseks ümardada üldsoovituste saamiseks ooteaegu ülespoole.
English: Half-lives reported for rafoxanide range between 7 and 16.6 days.
Estonian: Rafoksaniidi poolväärtusajad on vahemikus 7…16,6 ööpäeva.
English: In making recommendations for safe time spans to be applied between administration of a product and collection of milk for human consumption, consideration will also be given to ensuring compatibility with normal animal husbandry practices.
Estonian: Ravimi manustamise ja toidupiima kogumise vahele jäävate ohutute ooteaegade soovitamisel arvestatakse ka sobivust tavaliste loomakasvatustavadega.
English: Nitroxinil
Estonian: Nitroksiniil
English: Outcome
Estonian: Tulemus
English: Belgium Norbrook Laboratories Ltd Station Works
Estonian: Prantsusmaa Norbrook Laboratories Ltd Station Works
English: It was concluded that residues in pasma would be below 0.18 μg/l 78 days (11 weeks) after administration.
Estonian: Järeldati, et jääkide kontsentratsioon plasmas väheneb alla väärtuse 0,18 µg/l 78 ööpäevaga (11 nädalaga) pärast manustamist.
English: Pasteur - Filiala Filipesti SRL Str. Principala nr. 944 Filipestii de Padure Jud.
Estonian: Pasteur - Filiala Filipesti SRL Str. Principala nr. 944